Novel 3D capsule device to restrict kidney volume expansion on polycystic kidney progression: feasibility study in a rat model
- PMID: 34757576
- DOI: 10.1007/s40620-021-01160-5
Novel 3D capsule device to restrict kidney volume expansion on polycystic kidney progression: feasibility study in a rat model
Abstract
Background: Cystogenesis in polycystic kidney disease (PKD) is likely accelerated by various renal insults, including crystal deposition, that activate renal tubule obstruction and dilation. We developed a capsule-based device that can be applied to cystic kidneys to restrict tubular lumen dilatation and cyst expansion.
Methods: Kidney capsule devices were designed from computed tomography images of wild-type and Cy/+ rats. Capsule devices were surgically implanted on kidneys in six surgical sessions over a period of 14 months in 7 wild-type rats of 6.5-8 weeks (3 sham operations, 2 right, 2 left) and 6 Cy/+ rats of 6.5 weeks (2 sham, 3 left, 1 bilateral). After surgery, the rats were followed for 5.4-12.4 weeks' growth and sacrificed to retrieve the kidneys. During the follow-up, serum creatinine was measured and retrieved kidneys were weighed. Histological analysis including cystic area measurement and immunohistochemistry was performed.
Results: Morphometric capsule devices were configured and developed by an image processing technique and produced using a 3D printer. Encapsulated Cy/+ kidneys (n = 5; mean weight 3.64 g) were consistently smaller in size (by 21-36%; p < 0.001) than unencapsulated Cy/+ kidneys (n = 7; mean weight 5.52 g). Encapsulated Cy/+ kidneys (mean %cyst area: 29.4%) showed smaller histological cystic area (by 28-58%; p < 0.001) than unencapsulated Cy/+ kidneys (mean %cyst area 48.6%). Cell proliferation and macrophages were also markedly reduced in encapsulated Cy/+ kidneys, compared to unencapsulated Cy/+ kidneys.
Conclusions: We report a pilot feasibility study for the application of a novel morphometric 3D capsule device to the Cy/+ rat model showing restricted kidney volume expansion on polycystic kidney disease progression.
Keywords: 3D printing; Image-processing; Intervention; Polycystic kidney disease; Rodent experiment.
© 2021. Italian Society of Nephrology.
Comment in
-
Gird your kidneys? A novel approach to ADPKD therapeutics.J Nephrol. 2023 Apr;36(3):933-934. doi: 10.1007/s40620-022-01425-7. Epub 2022 Aug 12. J Nephrol. 2023. PMID: 35960431 No abstract available.
References
-
- Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G et al (2017) Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med 377:1930–1942 - DOI
-
- Grantham JJ (2008) Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359:1477–1485 - DOI
-
- Kunnen SJ, Malas TB, Semeins CM, Bakker AD, Peters DJM (2018) Comprehensive transcriptome analysis of fluid shear stress altered gene expression in renal epithelial cells. J Cell Physiol 233:3615–3628 - DOI
-
- Gudipaty SA, Lindblom J, Loftus PD, Redd MJ, Edes K, Davey CF et al (2017) Mechanical stretch triggers rapid epithelial cell division through Piezo1. Nature 543:118–121 - DOI
-
- Nagao S, Nishii K, Yoshihara D, Kurahashi H, Nagaoka K, Yamashita T et al (2008) Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat. Kidney Int 73:269–277 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
